Q2 2014 Holdings
Filed 2014-08-07 | 24 holdings | $64.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc.(ALNY) | COM | 02043Q107 | $39.2M | 621,288 | 60.9% |
| Agios Pharmaceuticals Inc.(AGIO) | COM | 00847X104 | $23.2M | 506,000 | 36.0% |
| Celgene Corp(CELG) | COM | 151020104 | $362.4K | 4,219,298 | 0.6% |
| Gilead Sciences Inc.(GILD) | COM | 375558103 | $289.2K | 3,488,496 | 0.4% |
| Incyte Corp(INCY) | COM | 45337C102 | $235.0K | 4,163,790 | 0.4% |
| Isis Pharmaceuticals Inc. | COM | 464330109 | $231.0K | 6,706,526 | 0.4% |
| Vertex Pharmaceuticals Inc.(VRTX) | COM | 92532F100 | $133.0K | 1,404,445 | 0.2% |
| Medivation Inc. | COM | 58501N101 | $115.6K | 1,499,706 | 0.2% |
| Alexion Pharmaceuticals Inc.(ALXN) | COM | 015351109 | $113.7K | 727,428 | 0.2% |
| Synageva BioPharma Corp. | COM | 87159A103 | $94.2K | 898,476 | 0.1% |
| Regeneron Pharmaceuticals Inc.(REGN) | COM | 75886F107 | $65.8K | 233,000 | 0.1% |
| Pharmacyclics Inc. | COM | 716933106 | $65.6K | 731,542 | 0.1% |
| Halozyme Therapeutics Inc.(HALO) | COM | 40637H109 | $57.8K | 5,846,564 | 0.1% |
| Neurocrine Biosciences Inc.(NBIX) | COM | 64125C109 | $45.8K | 3,086,552 | 0.1% |
| Puma Biotechnology Inc.(PBYI) | COM | 74587V107 | $38.1K | 576,991 | 0.1% |
| ImmunoGen Inc.(IMGNEUR) | COM | 45253H101 | $37.5K | 3,165,816 | 0.1% |
| Radius Health Inc | COM | 750469207 | $35.7K | 2,745,040 | 0.1% |
| Theravance Inc. | COM | 88338T104 | $27.8K | 933,244 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $23.1K | 558,188 | 0.0% |
| Tesaro Inc. | COM | 881569107 | $21.9K | 704,582 | 0.0% |
| Infinity Pharmaceuticals Inc.(INFIQ) | COM | 45665G303 | $19.2K | 1,505,737 | 0.0% |
| Endocyte Inc. | COM | 29269A102 | $16.2K | 2,463,522 | 0.0% |
| Achillion Pharmaceuticals Inc.(ACHNEUR) | COM | 00448Q201 | $13.5K | 1,779,340 | 0.0% |
| Cubist Pharmaceuticals Inc. | RIGHT 99/99/9999 | 229678123 | $101 | 876,273 | 0.0% |